Ceftriaxone+Sulbactam+Disodium EDTA Versus Meropenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: PLEA, a Double-Blind, Randomized Noninferiority Trial

BACKGROUND: CSE is a novel combination of ceftriaxone, sulbactam, and disodium ethylenediaminetetraacetic acid (EDTA) with activity against multidrug-resistant Gram-negative pathogens. METHODS: Adult patients aged ≥18 years with a diagnosis of complicated urinary tract infections (cUTIs), including...

Descripción completa

Detalles Bibliográficos
Autores principales: Mir, Mohd Amin, Chaudhary, Saransh, Payasi, Anurag, Sood, Rajeev, Mavuduru, Ravimohan S, Shameem, Mohd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767967/
https://www.ncbi.nlm.nih.gov/pubmed/31433059
http://dx.doi.org/10.1093/ofid/ofz373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767967/
https://www.ncbi.nlm.nih.gov/pubmed/31433059
http://dx.doi.org/10.1093/ofid/ofz373

Ejemplares similares